Glytherix hopes to find a cure for challenging cancers like pancreatic, bladder, oesophageal, and glioblastoma.
Former Macquarie executive Bill Moss is backing Sydney-based Glytherix with his personal fortune to run clinical trials for the biotech’s flagship cancer treatment.
Macquarie veteran Bill Moss. Jeremy Piper
Gift articles to anyone you choose each month when you subscribe.
Compare how 6 other independent news outlets reported on this story.
Men aged 50–69 and at average risk should get PSA screening every two years.
Paris-based Orakl Oncology has raised a $34M Series A to predict how cancer drugs will perform, using lab-grown copies of patients' tumours and AI.
One of the leading cancer organizations in the United States is raising the alarm over prostate cancer and directly urging men to get screened.
Speaking to author Robert Macfarlane in a rare interview about her cancer diagnosis, the Princess of Wales described the role nature played in her recovery.
Researchers discover a potential diagnostic breakthrough for a disease often discovered after it has already spread
The corporate regulator said customers should not have to scrutinise every transaction and that Macquarie had failed to prevent confusion to customers.
